SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
|
3 Months Ended |
Mar. 31, 2022 |
|---|
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
|
| Schedule of financial assets and liabilities measured at fair value on recurring basis |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements |
|
|
as of March 31, 2022 Using: |
|
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Warrant liability |
|
$ |
— |
|
$ |
12,253 |
|
$ |
— |
|
$ |
12,253 |
Contingent consideration |
|
|
— |
|
|
— |
|
|
13,379,797 |
|
|
13,379,797 |
Derivative liability |
|
|
— |
|
|
— |
|
|
2,664,171 |
|
|
2,664,171 |
|
|
$ |
— |
|
$ |
12,253 |
|
$ |
16,043,968 |
|
$ |
16,056,221 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements |
|
|
as of December 31, 2021 Using: |
|
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Warrant liability |
|
$ |
— |
|
$ |
18,223 |
|
$ |
— |
|
$ |
18,223 |
Contingent consideration |
|
|
— |
|
|
— |
|
|
12,179,476 |
|
|
12,179,476 |
Derivative liability |
|
|
— |
|
|
— |
|
|
2,294,720 |
|
|
2,294,720 |
|
|
$ |
— |
|
$ |
18,223 |
|
$ |
14,474,196 |
|
$ |
14,492,419 |
|
| Schedule of changes in contingent consideration |
|
|
|
|
|
|
Contingent |
|
|
Consideration |
|
|
Liability |
Outstanding as of December 31, 2021 |
|
$ |
12,179,476 |
Change in fair value |
|
|
1,200,321 |
Outstanding as of March 31, 2022 |
|
$ |
13,379,797 |
|
| Summary of changed in derivative liability |
|
|
|
|
|
|
Derivative |
|
|
Liability |
Outstanding as of December 31, 2021 |
|
$ |
2,294,720 |
Conversion of underlying notes into common stock |
|
|
(312,652) |
Change in fair value |
|
|
682,103 |
Outstanding as of March 31, 2022 |
|
$ |
2,664,171 |
|
| Schedule of Current Inventory |
|
|
|
|
|
|
|
|
|
March 31, |
|
December 31, |
|
|
2022 |
|
2021 |
Raw materials |
|
$ |
412,748 |
|
$ |
292,167 |
Work in process |
|
|
235,867 |
|
|
242,673 |
Finished goods |
|
|
1,843,990 |
|
|
2,220,519 |
Inventory |
|
$ |
2,492,605 |
|
$ |
2,755,358 |
|
| Schedule of potentially dilutive items outstanding |
|
|
|
|
|
|
|
March 31, |
|
|
2022 |
|
2021 |
Convertible notes |
|
5,164,752 |
|
— |
Series Seed Preferred Stock (convertible to common stock) |
|
— |
|
20,714,518 |
Series A Preferred Stock (convertible to common stock) |
|
— |
|
5,654,072 |
Series A-2 Preferred Stock (convertible to common stock) |
|
— |
|
5,932,742 |
Series CF Preferred Stock (convertible to common stock) |
|
— |
|
836,331 |
Series A-3 Preferred Stock (convertible to common stock) |
|
— |
|
9,032,330 |
Series B Preferred Stock (convertible to common stock) |
|
— |
|
20,754,717 |
Common stock warrants |
|
914,539 |
|
914,539 |
Preferred stock warrants |
|
— |
|
806,903 |
Stock options |
|
3,895,103 |
|
1,163,103 |
Total potentially dilutive shares |
|
9,974,393 |
|
65,809,254 |
|